Clinton Health Access Initiative Inc is located in Boston, MA. The organization was established in 2010. According to its NTEE Classification (Q33) the organization is classified as: International Relief, under the broad grouping of International, Foreign Affairs & National Security and related organizations. As of 12/2023, Clinton Health Access Initiative Inc employed 274 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Clinton Health Access Initiative Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Clinton Health Access Initiative Inc generated $224.7m in total revenue. This represents relatively stable growth, over the past 8 years the organization has increased revenue by an average of 3.5% each year. All expenses for the organization totaled $225.6m during the year ending 12/2023. While expenses have increased by 5.2% per year over the past 8 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2012, Clinton Health Access Initiative Inc has awarded 268 individual grants totaling $45,380,205. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
THE CLINTON HEALTH ACCESS INITIATIVE, INC. (CHAI) IS A GLOBAL HEALTH ORGANIZATION THAT ENVISIONS A WORLD IN WHICH EVERYONE IS ABLE TO LIVE A HEALTHY AND FULFILLING LIFE. WE ARE COMMITTED TO SAVING LIVES AND IMPROVING HEALTH OUTCOMES BY ENABLING THE GOVERNMENT AND PRIVATE SECTOR TO STRENGTHEN AND SUSTAIN QUALITY HEALTH SYSTEMS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
OUR PROGRAMS AIM TO SAVE LIVES AND REDUCE THE BURDEN OF DISEASE, WHILE HELPING GOVERNMENTS CREATE SUSTAINABLE HEALTH SYSTEMS. WE OPERATE IN OVER 35 COUNTRIES AND SUPPORT MORE THAN 20 DIFFERENT HEALTH PROGRAMS. THE VAST MAJORITY OF OUR STAFF ARE LOCATED IN THE COUNTRIES WHERE WE WORK, OVERSEEING IMPLEMENTATION AND MANAGING RELATIONSHIPS WITH PARTNER GOVERNMENTS. THE TEAMS ON THE GROUND ARE COMPLEMENTED BY A GLOBAL TEAM OF SCIENCE, BUSINESS, AND TECHNICAL EXPERTS SUPPORTING THE ENTIRE ORGANIZATION AND BY MANAGEMENT, FINANCE, AND HUMAN RESOURCE TEAMS. INFECTIOUS DISEASES: SEE SCHEDULE O FOR CONTINUATIONINFECTIOUS DISEASES: FOR YEARS, FOUR INFECTIOUS DISEASES DROVE MOST ILLNESS AND DEATH WORLDWIDE: HIV, HEPATITIS, TUBERCUOSIS (TB), AND MALARIA. IN 2020, A NEW ILLNESS, COVID-19, WAS ADDED TO THIS LIST.EARLY ON, THE PANDEMIC BROUGHT MANY HEALTH SYSTEMS TO THEIR KNEES, AND IT CONTINUES TO EXPOSE AND EXACERBATE INEQUITIES THAT ALREADY EXISTED BETWEEN COUNTRIES, PEOPLE, AND ACCESS TO BASIC HEALTH SERVICES. IN 2023, CHAI CONTINUED TO SUPPORT COUNTRIES' LONGTERM RESPONSE TO COVID-19 AND STRENGTHEN HEALTH SYSTEM RESLIENCE TO PREPARE FOR FUTURE PANDEMICS.A CORE COMPONENT OF THIS WORK HAS BEEN STRENGTHENING ACCESS TO MEDICAL OXYGEN IN HEALTHCARE FACILITIES AND HOSPITALS IN LOW- AND MIDDLE-INCOME COUNTRIES THROUGH UPDATING INFRASTRUCTURE (I.E. BUILDING PRESSURE SWING ADSORPTION (PSA) PLANTS; SUPPORTING BEDSIDE DELIVERY OF LIQUID OXYGEN), KEEP OXYGEN EQUIPMENT UP AND RUNNING FOR ITS FULL LIFESPAN AND PROVIDING HEALTH WORKERS WITH THE RIGHT TOOLS, PROCESSES, AND PRACTICES TO SAVE LIVES.AT THE SAME TIME WE CONTINUE TO WORK ON THE DISEASE AREAS THAT WE HAVE FOCUSED ON FOR DECADES, INCLUDING HIV AND ADVANCED HIV DISEASE.FOR EXAMPLE, OUR WORK TO INTRODUCE AFFORDABLE, MORE PALATABLE HIV TREATMENTS FOR CHILDREN. THERE HAVE BEEN VAST IMPROVEMENTS IN PEDIATRIC HIV TREATMENT IN RECENT YEARS, INCLUDING THE RAPID DEVELOPMENT AND INTRODUCTION OF GENERIC PEDIATRIC DOLUTEGRAVIR TABLETS, WHICH DISSOLVE IN WATER AND TASTE LIKE STRAWBERRIES, DRAMATICALLY INCREASING CHILDREN'S ADHERENCE TO THEIR TREATMENT REGIMEN. CHAI IS WORKING WITH PARTNERS TO DRIVE THE DEVELOPMENT AND INTRODUCTION OF MORE GENERIC VERSIONS OF BEST-IN-CLASS CHILDREN'S MEDICATIONS.
WOMEN & CHILDREN'S HEALTH: SEE SCHEDULE O FOR CONTINUATIONWOMEN & CHILDREN'S HEALTH: WOMEN AND CHILDREN SUFFER THE GREATEST BURDEN FROM DISEASE GLOBALLY. CHAI HAS SIGNIFICANTLY INCREASED ACCESS TO RECOMMENDED TREATMENTS FOR DIARRHEA AND PNEUMONIA, THE LARGEST KILLERS OF CHILDREN UNDER FIVE; MADE CRITICAL VACCINES THAT PROTECT AGAINST CHILDHOOD ILLNESSES MORE AFFORDABLE; IS COMBATTING CHRONIC MALNUTRITION; AND IS DRAMATIALLY AND SUSTAINABLY REDUCING MATERNAL AND NEWBORN DEATHS AND ENSURING WOMEN HAVE ACCESS TO THE TOOLS THEY NEED TO SAFELY PLAN THER FAMILIES TO IMPROVE HEALTH OUTCOMES AND ECONOMIC WELLBEING.FOR EXAMPLE, WHEN CHAI BEGAN OUR DIARRHEA PROGRAM IN 2012, ONLY ONE-THIRD OF CHILDREN THAT NEEDED LIFESAVING ORAL REHYDRATION SOLUTIONS (ORS) RECEIVED IT. ZINC USAGE RATES WERE EVEN WORSE. THROUGH CHAI'S MARKET SHAPING WORK, WE HELPED REDUCE THE AVERAGE COST OF ZINC/ORS TREATMENT BY 42 PERCENT. WORKING WITH PARTNERS IN INDIA, KENYA, NIGERIA, AND UGANDA, WE ALSO INCREASED THE PERCENTAGE OF CHILDREN WITH DIARRHEA RECEIVING ZINC/ORS FROM LESS THAN ONE PERCENT TO 24 PERCENT.ANOTHER STRONG EXAMPLE IS CHAI'S WORK TO SAVE THE LIVES OF WOMEN AND NEWBORNS. CHAI HAS DEVELOPED AN INTEGRATED MATERNAL, NEWBORN, AND REPRODUCTIVE HEALTH STRATEGY THAT HAS CONTRIBUTED TO SUSTAINED AND SIGNFICANT REDUCTIONS IN DEATH IN COUNTRIES WHERE WE WORK. THIS APPROACH WAS FIRST PILOTED IN ETHIOPIA, BEFORE BEING TESTED AT SCALE IN NIGERIA, WHERE WE SAW A NEARLY 40 PERCENT REDUCTION IN MATERNAL MORTALITY AND A 43 PERCENT REDUCTION IN NEWBORN DEATHS IN A 12- MONTH PERIOD IN TARGET STATES OF NORTHERN NIGERIA. THE PROGRAM HAS BEEN ROLLED OUT MORE RECENTLY IN ZAMBIA AND UGANDA WITH SIMILAR RESULTS.
NON-COMMUNICABLE DISEASES: SEE SCHEDULE O FOR CONTINUATIONNON-COMMUNICABLE DISEASES (NCDS) SUCH AS HEART DISEASE, CANCER, CHRONIC RESPIRATORY DISEASE, AND DIABETES ARE THE LEADING CAUSE OF DEATH GLOBALLY, EXCEEDING ALL COMMUNICABLE DISEASE DEATHS COMBINED.IN ADDITION TO OUR NCD PROGRAM, WHICH SUPPORTS GOVERNMENTS TO STRENGTHEN AND IMPLEMENT THEIR NCD PREVENTION AND CONTROL STRATEGIES, CHAI IS PARTNERING WITH GOVERNMENTS TO STRENGTHEN CANCER CARE SYSTEMS BY SOLVING CRITICAL SYSTEMIC GAPS. WE BELIEVE BY WORKING IN CLOSE COLLABORATION WITH PARTNER GOVERNMENTS AND BY ANCHORING A SUITE OF TRANSFORMATIONAL INTERVENTIONS, WE CAN DRAMATICALLY IMPROVE SURVIVAL RATES OF CANCER PATIENTS IN LOW- AND MIDDLE-INCOME COUNTRIES. FOR EXAMPLE, OVER THE LAST FOUR YEARS, WE HAVE HELPED SHAPE GLOBAL MARKETS TO RAPIDLY EXPAND ACCESS TO HIGH-QUALITY TOOLS TO SCREEN AND TREAT CERVICAL PRE-CANCER, INCLUDING HUMAN PAPILLOMAVIRUS (HPV) TESTS AND THERMAL ABLATION DEVICES.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Joy Phumaphi Board Member | Trustee | 1 | $0 |
Alan Schwartz Board Member | Trustee | 1 | $0 |
Raymond Chambers Board Member | Trustee | 1 | $0 |
Chelsea Clinton Board Member | Trustee | 10 | $0 |
William J Clinton Board Member | Trustee | 5 | $0 |
Aliko Dangote Board Member | Trustee | 1 | $0 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Global Human Access Resources Limited Information Systems | 12/30/23 | $3,401,298 |
White Coral Consulting Dmmc Employment Management | 12/30/23 | $567,228 |
Health Strat Ltd Health System Solutions | 12/30/23 | $541,088 |
Afrida Management Systems | 12/30/23 | $352,152 |
Muhas Research Study | 12/30/23 | $259,906 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $93,990,771 |
All other contributions, gifts, grants, and similar amounts not included above | $127,279,819 |
Noncash contributions included in lines 1a–1f | $3,976,801 |
Total Revenue from Contributions, Gifts, Grants & Similar | $221,270,590 |
Total Program Service Revenue | $0 |
Investment income | $3,182,094 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $8,355 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $224,653,300 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $5,089,916 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $25,147,683 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $4,112,155 |
Compensation of current officers, directors, key employees. | $975,433 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $77,164,201 |
Pension plan accruals and contributions | $4,786,908 |
Other employee benefits | $22,380,849 |
Payroll taxes | $4,825,899 |
Fees for services: Management | $0 |
Fees for services: Legal | $560,560 |
Fees for services: Accounting | $988,232 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $11,140 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $14,216,035 |
Advertising and promotion | $0 |
Office expenses | $4,862,071 |
Information technology | $0 |
Royalties | $0 |
Occupancy | $2,695,362 |
Travel | $20,708,460 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $7,092,181 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $106,816 |
Insurance | $461,629 |
All other expenses | $449,664 |
Total functional expenses | $225,603,286 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $0 |
Savings and temporary cash investments | $14,272,378 |
Pledges and grants receivable | $19,691,121 |
Accounts receivable, net | $5,437,254 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $2,100,893 |
Net Land, buildings, and equipment | $350,142 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $118,884,701 |
Total assets | $160,736,489 |
Accounts payable and accrued expenses | $16,161,223 |
Grants payable | $0 |
Deferred revenue | $132,526,959 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $1,021,468 |
Total liabilities | $149,709,650 |
Net assets without donor restrictions | $9,868,754 |
Net assets with donor restrictions | $1,158,085 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $160,736,489 |
Over the last fiscal year, Clinton Health Access Initiative Inc has awarded $5,428,375 in support to 22 organizations.
Grant Recipient | Amount |
---|---|
BLUE EQ PURPOSE: HEALTH | $6,980 |
SABOT IMPACT ADVISORS PURPOSE: HEALTH | $12,000 |
TERRAFRAME INC PURPOSE: HEALTH | $17,280 |
GEORGETOWN UNIVERSITY PURPOSE: HEALTH | $24,980 |
VITALLIANCE CORPORATION PURPOSE: HEALTH | $25,000 |
AKROS INC PURPOSE: HEALTH | $25,298 |